Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

10 results
Display

What’s new in kidney tumor pathology 2022: WHO 5th edition updates

Tretiakova M

The 5th edition WHO Classification of Urinary and Male Genital Tumours (2022) introduces significant changes relevant to daily practice, especially in the completely restructured renal cell tumor chapters. Herein we...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
What’s new in soft tissue and bone pathology 2022–updates from the WHO classification 5th edition

Kao EY, Mantilla JG

The 2020 release of the WHO Classification of Soft Tissue and Bone Tumors, 5th edition, contains several changes driven by new knowledge in the field. These include reclassification of some...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Biomarker testing of cytology specimens in personalized medicine for lung cancer patients

Kim H, Chung JH

Every patient with advanced non–small cell lung cancer (NSCLC) should be tested for targetable driver mutations and gene arrangements that may open avenues for targeted therapy. As most patients with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Usefulness of BRAF VE1 immunohistochemistry in non–small cell lung cancers: a multi-institutional study by 15 pathologists in Korea

Chang S, Choi YL, Shim HS, Lee GK, Ha SY, Korean Cardiopulmonary Pathology Study Group

Background: Next-generation sequencing (NGS) is an approved test to select patients for BRAF V600E targeted therapy in Korea. However, the high cost, long turnaround times, and the need for sophisticated...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Development of quality assurance program for digital pathology by the Korean Society of Pathologists

Chong Y, Bae JM, Kang DW, Kim G, Han HS

Background: Digital pathology (DP) using whole slide imaging is a recently emerging game changer technology that can fundamentally change the way of working in pathology. The Digital Pathology Study Group...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: its updated diagnostic criteria, preoperative cytologic diagnoses and impact on the risk of malignancy

Na HY, Park SY

Due to the extremely indolent behavior, a subset of noninvasive encapsulated follicular variant papillary thyroid carcinomas has been classified as “noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)” since...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The application of high-throughput proteomics in cytopathology

Nikas IP, Ryu HS

High-throughput genomics and transcriptomics are often applied in routine pathology practice to facilitate cancer diagnosis, assess prognosis, and predict response to therapy. However, the proteins rather than nucleic acids are...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Current status of cytopathology practice in Korea: impact of the coronavirus pandemic on cytopathology practice

Hong SA, Jung H, Kim SS, Jin MS, Pyo JS, Jeong JY, Choi Y, Gong G, Chong Y, The Committee of Quality Improvement of Korean Society for Cytopathology

Background: The Continuous Quality Improvement program for cytopathology in 2020 was completed during the coronavirus pandemic. In this study, we report the result of the quality improvement program. Methods: Data...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Diagnostic distribution and pitfalls of glandular abnormalities in cervical cytology: a 25-year single-center study

Sung JA, Nikas IP, Kim H, Ryu HS, Lee C

Background: Detection of glandular abnormalities in Papanicolaou (Pap) tests is challenging. This study aimed to review our institute’s experience interpreting such abnormalities, assess cytohistologic concordance, and identify cytomorphologic features associated...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A clinicopathologic and immunohistochemical study of primary and secondary breast angiosarcoma

Abada E, Jang H, Kim S, Ali-Fehmi R, Bandyopadhyay S

Background: We aimed to study the clinicopathologic and immunohistochemical (IHC) (CD117, c-Myc, and p53) characteristics, and overall survival of primary and secondary breast angiosarcoma (BAS). Methods: This was a retrospective...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr